HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

hLL2 agent (epratuzumab)

Also Known As:
epratuzumab; LymphoCide
Networked: 68 relevant articles (10 outcomes, 29 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goldenberg, David M: 26 articles (12/2015 - 08/2003)
2. Wegener, William A: 12 articles (07/2015 - 08/2003)
3. Leonard, John P: 8 articles (11/2013 - 02/2002)
4. Dörner, Thomas: 6 articles (12/2015 - 01/2006)
5. Coleman, Morton: 5 articles (11/2008 - 08/2003)
6. Cesano, Alessandra: 5 articles (02/2007 - 04/2003)
7. Chang, Chien-Hsing: 4 articles (01/2015 - 10/2010)
8. Hansen, Hans J: 4 articles (02/2007 - 08/2003)
9. Shock, Anthony: 3 articles (12/2015 - 10/2012)
10. Wallace, Daniel J: 3 articles (01/2014 - 07/2013)

Related Diseases

1. Systemic Lupus Erythematosus (Libman-Sacks Disease)
2. Non-Hodgkin Lymphoma (Lymphosarcoma)
3. Autoimmune Diseases (Autoimmune Disease)
4. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
5. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. rituximab (Mabthera)
2. belimumab
3. Antibodies
4. Vincristine (Oncovin)
5. alemtuzumab (Campath)
6. Doxorubicin (Adriamycin)
7. Prednisone (Sone)
8. Immunoglobulins (Immunoglobulin)
9. Immunoglobulin G (IgG)
10. Cyclophosphamide (Cytoxan)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radioimmunotherapy
3. Immunotherapy
4. Stents
5. Heterologous Transplantation (Xenotransplantation)